Cancer drugs. Weighing the risks and benefits.

FDA consumer Pub Date : 2007-01-01

Linda Bren

引用次数: 0

Abstract

Few deliberations have greater bearing on human health than when the Food and Drug Administration weighs the risks and benefits of drugs designed to treat life-threatening diseases, such as cancer.

本刊更多论文

癌症药物。权衡风险和收益。

当美国食品和药物管理局(Food and Drug Administration)权衡用于治疗癌症等危及生命的疾病的药物的风险和益处时，很少有比这更关乎人类健康的考虑了。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

FDA consumer

自引率

0.00%

发文量